Julius Knowles Keros Therapeutics, Inc. (KROS) insider trading activity
Julius Knowles is of Keros Therapeutics, Inc.. Currently has a direct ownership of 6,441 shares of KROS, which is worth approximately $97,838. The most recent transaction as insider was on Jun 04, 2025, when has been sold 5,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
        Shares Held (Direct Ownership)
        6.44K
                  
          
      
      
    
                  
                    0%
                  
            3M change
          
                    
          
          
                
                   440.81%
                
             12M change
          
                    
        
        Total Value Held
          $97,838
      
      
    
        JK
    
    
    Julius Knowles
        
        Lexington, MA